About Us Products in Development Patients & Caregivers Investors & Media Partnering
Sunesis Pharmaceuticals - Inspired to Make a Difference in Cancer Patients Lives.

Sunesis In The News

Dec 05 2019
Sunesis Pharmaceuticals Announces Data from Ongoing Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and Other B-Cell Malignancies

Nov 12 2019
Sunesis Pharmaceuticals Reports Third Quarter 2019 Financial Results and Recent Highlights

Nov 08 2019
Sunesis Pharmaceuticals to Present at 28th Annual Credit Suisse Healthcare Conference

Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics.

With a passion to advance novel drugs, we are inspired to make a difference in cancer patients' lives!



Want to learn more about
Chronic Lymphocytic Leukemia?
Please visit:
Know AML - World Awareness Day 21 April
CLLS is a patient–centric, physician–curated nonprofit organization focused on patient education, support and research dedicated to addressing the unmet needs of the CLL (chronic lymphocytic leukemia) community.
© 2019 Sunesis Pharmaceuticals, Inc. - SVR-WEB00-SYM
Contact Us | Careers | Terms of Use | Site Map